z-logo
open-access-imgOpen Access
Nanoprobes‐Assisted Multichannel NIR‐II Fluorescence Imaging‐Guided Resection and Photothermal Ablation of Lymph Nodes
Author(s) -
Fan Xiaoxiao,
Li Yirun,
Feng Zhe,
Chen Guoqiao,
Zhou Jing,
He Mubin,
Wu Lan,
Li Shengliang,
Qian Jun,
Lin Hui
Publication year - 2021
Publication title -
advanced science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.388
H-Index - 100
ISSN - 2198-3844
DOI - 10.1002/advs.202003972
Subject(s) - photothermal therapy , fluorescence lifetime imaging microscopy , lymphadenectomy , lymph , lymphatic system , ablation , materials science , lymph node , fluorescence , biomedical engineering , medicine , nanotechnology , pathology , optics , physics
Lymph node metastasis is a major metastatic route of cancer and significantly influences the prognosis of cancer patients. Radical lymphadenectomy is crucial for a successful surgery. However, iatrogenic normal organ injury during lymphadenectomy is a troublesome complication. Here, this paper reports a kind of organic nanoprobes (IDSe‐IC2F nanoparticles (NPs)) with excellent second near‐infrared (NIR‐II) fluorescence and photothermal properties. IDSe‐IC2F NPs can effectively label lymph nodes and helped achieve high‐contrast lymphatic imaging. More importantly, by jointly using IDSe‐IC2F nanoparticles and other kinds of nanoparticles with different excitation/emission properties, a multichannel NIR‐II fluorescence imaging modality and imaging‐guided lymphadenectomy is proposed. With the help of this navigation system, the iatrogenic injury can be largely avoided. In addition, NIR‐II fluorescence imaging‐guided photothermal treatment (“hot” strategy) can ablate those metastatic lymph nodes which are difficult to deal with during resection (“cold” strategy). Nanoprobes‐assisted and multichannel NIR‐II fluorescence imaging‐guided “cold” and “hot” treatment strategy provides a general new basis for the future precision surgery.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here